Search results
Miller develops new biomaterials, 3D printing methodologies, and sacrificial casting strategies to enable the rapid fabrication of engineered tissues containing perfusable vascular architectures. Patterned vasculature facilitates capillary sprouting and supports the function of primary parenchymal cells in centimeter-sized constructs.
- Rice professor, grad student strike $45 million deal for startup
Houston-based Volumetric Biotechnologies, a 3D bioprinting...
- Miller awarded Kleberg Foundation Medical ... - Rice University
Rice University bioengineer Jordan Miller develops novel...
- Rice professor, grad student strike $45 million deal for startup
Oct 28, 2021 · Houston-based Volumetric Biotechnologies, a 3D bioprinting company founded by Rice bioengineers Jordan Miller and Bagrat Grigoryan ‘19, has been purchased by 3D Systems for an initial payment of $45 million in cash and stock and up to $355 million in future performance bonuses.
Adjunct Associate Professor of Bioengineering, Rice University - Cited by 8,716 - Biomaterials - Tissue Engineering - Microfabrication - Angiogenesis - Regenerative Medicine
View Jordan Miller’s profile on LinkedIn, a professional community of 1 billion members. Experience: Rice University · Education: Rice University · Location: Houston · 500+ connections on...
- 500+
- Rice University
- 4.4K
- Houston, Texas, United States
Jordan Miller is the SVP, Chief Scientist for Regenerative Medicine at 3D Systems, which acquired Volumetric, in 2021. Jordan Miller received his PhD from Rice University in 2008, returned to the Department of Bioengineering as an Assistant Professor in 2013.
Engineering vasculature with bioprinting, 3d printing, biofabrication with Professor Jordan Miller from Rice University, and co-Founder of Volumetric.
Rice University bioengineer Jordan Miller develops novel biomaterials and 3D bioprinting systems for next-generation tissue engineering applications. These technologies aim to build living tissue architectures that can closely mimic features of native vascular networks within three-dimensional hydrogel scaffolds containing live cells.
